Alanis Morissette Sues Former Israeli Tour Manager for Extortion
Singer Alanis Morissette has filed a lawsuit against her former tour manager, Keren Orinov, an Israeli national who previously worked with Live Nation in Israel. Morissette alleges that Orinov attempted to extort her by threatening to implicate her in drug trafficking in the UK unless she was granted a 15-year employment contract and significant financial compensation.
According to the lawsuit, obtained by CBC News, Orinov was hired temporarily in 2025 to manage Morissette's world tour. In July of that year, while traveling from the UK to Spain, British border officials found a bag containing marijuana and xylazine, a veterinary anesthetic. Orinov reportedly told authorities the bag and its contents were hers and presented an Israeli medical cannabis license. She was released but detained again the following day for questioning.
Morissette claims that after the tour concluded, Orinov and her lawyers began sending letters threatening legal action in the UK if Morissette did not claim ownership of the drugs. Orinov allegedly proposed a resolution: a permanent 15-year contract as a tour manager with salary increases and bonuses. She also demanded Morissette fund an immigration lawyer for a US work visa, with additional compensation if the visa was denied.
Morissette is suing Orinov for civil extortion, fraud, and negligent misrepresentation, stating she will not yield to the pressure. The lawsuit also details alleged financial mismanagement during the tour, including a hotel booking error that cost nearly $70,000. Morissette further claims Orinov told the tour staff that she had previously been arrested for drug smuggling in Latin America and fled the country while out on bail. These allegations have not yet been proven in court.
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.